Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00478764 · ClinicalTrials.gov registry record · NA

Intraocular Steroid After Cataract Surgery Study

A NA study of Cataract, sponsored by Dean Health System.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT00478764 is a NA study of Cataract that has completed, run by Dean Health System. The registered enrollment target is 41 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00478764, a NA study of Cataract, has completed, sponsored by Dean Health System.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.

Conditions Studied

Interventions

  • DRUG intraocular triamcinolone and gatifloxicin

Study Locations (1)

Wisconsin

  • Davis Duehr Dean Baraboo - Baraboo

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2006-03
Est. Completion 2007-04
Phase NA

Sponsor

Dean Health System

1 total trials

What the Registry Record Tells You About NCT00478764

The ClinicalTrials.gov registry entry for NCT00478764 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Dean Health System, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which intraocular triamcinolone and gatifloxicin is the first listed.

NCT00478764 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00478764 about?

NCT00478764 is a clinical study titled "Intraocular Steroid After Cataract Surgery Study". The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.

What is the current status of trial NCT00478764?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2006-03. Estimated completion is 2007-04.

What conditions does trial NCT00478764 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT00478764?

The interventions under investigation include: intraocular triamcinolone and gatifloxicin (DRUG).

Who is sponsoring clinical trial NCT00478764?

This trial is sponsored by Dean Health System, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00478764 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.